MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-23-2026
BioNano Genomics Operating Cycle 2011-2026 | BNGO
Annual Operating Cycle BioNano Genomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 315 | 329 | 477 | 430 | 281 | 330 | 414 | 182 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 477 | 182 | 345 |
Quarterly Operating Cycle BioNano Genomics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 263 | 351 | 377 | - | 211 | 499 | 486 | - | 538 | 547 | 622 | - | 248 | 180 | 354 | - | 238 | 207 | 205 | - | 323 | 716 | 726 | 393 | 307 | 468 | 447 | 135 | 177 | 175 | 353 | 211 | 101 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 726 | 101 | 352 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K |  USA |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Sotera Health Company
SHC
|
80.3 | $ 13.28 | -1.96 % | $ 3.77 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 14.59 | -0.07 % | $ 1.89 B | USA |
 |
Agilent Technologies
A
|
161 | $ 110.88 | -2.29 % | $ 33.7 B | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 16.57 | -10.43 % | $ 178 M |  China |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
202 | $ 62.48 | -5.47 % | $ 24.4 B | USA |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
405 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | China |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 15.62 | -4.64 % | $ 472 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
Guardant Health
GH
|
128 | $ 85.04 | -3.47 % | $ 10.7 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
97.9 | $ 24.15 | -2.23 % | $ 671 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 158.32 | -4.12 % | $ 7.85 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 196.15 | -1.01 % | $ 21.8 B | USA |
 |
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 101.83 | -1.21 % | $ 8.4 B |  Irlanda |
 |
DarioHealth Corp.
DRIO
|
227 | $ 8.45 | - | $ 33.7 M |  Israel |
 |
Illumina
ILMN
|
198 | $ 117.51 | -5.54 % | $ 18.7 B | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
79.2 | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
IQVIA Holdings
IQV
|
73.9 | $ 164.58 | -2.85 % | $ 28.3 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
213 | $ 8.84 | -3.39 % | $ 1.92 B | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Personalis
PSNL
|
55.8 | $ 6.4 | -12.64 % | $ 379 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 266.29 | -0.78 % | $ 22.2 B | USA |
 |
Senseonics Holdings
SENS
|
104 | $ 6.54 | -0.3 % | $ 273 M | USA |
 |
Psychemedics Corporation
PMD
|
61.3 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
49.8 | $ 26.03 | -1.92 % | $ 33.8 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 16.83 | -3.66 % | $ 897 M | USA |
 |
Quotient Limited
QTNT
|
432 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Syneos Health
SYNH
|
102 | - | - | $ 4.46 B | USA |